Nippon Life India AMC Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹77,098 Cr
- Book Value
- ₹73
- Stock P/E
- 47.1
- Dividend Yield
- 1.79%
- ROE
- 34.5%
- ROCE
- 43.8%
- PEG Ratio
- 2.68
- EV/EBITDA
- 35.5
Fundamentals from Screener.in, as of 5 Aug 2026. Live price via Yahoo Finance.
Nippon Life India AMC share price today
Nippon Life India AMC (NSE: NAM-INDIA) runs the industry’s largest retail folio base — more individual investor accounts than any rival — plus the leading ETF franchise by volume. Same toll-booth model as every AMC: AUM × fee, minimal capital, which at Nippon’s scale means a 66.7% operating margin, 43.8% ROCE, zero debt, and a 1.8% dividend from cash it cannot reinvest fast enough.
The story since the Nippon Life (Japan) takeover from Reliance Capital: rebuilt institutional trust, market-share recovery, and a retail engine that mints folios in smaller towns faster than anyone. At 47.1×, our universe tags it wait — the cheaper-growth cousin of HDFC AMC, at a price that is no longer cheap in absolute terms.
Folios are the moat
Retail folios are stickier than corporate money — small SIPs survive market corrections that make institutions flee — and Nippon’s B30 (beyond-top-30-cities) distribution catches India’s investing habit where it is being born. The ETF leadership adds an option: if India’s passive shift accelerates, the incumbent volume leader in ETFs wins twice, fee-thin but AUM-thick.
Watch-items: TER regulation (the sector-wide swing), equity-market drawdowns marking AUM down, active-fund performance versus benchmarks (flows follow alpha), and yield compression as the passive mix grows.
The numbers
From our research universe snapshot (5 Aug 2026):
| Metric | Value |
|---|---|
| Market cap | ₹77,098 Cr |
| P/E (TTM) | 47.1 |
| EV/EBITDA | 35.5 |
| Operating margin | 66.7% |
| ROE / ROCE | 34.5% / 43.8% |
| Debt to equity | 0.02 |
| Sales CAGR (5y) | 15.6% |
| Profit CAGR (5y) | 17.6% |
| Promoter holding | 71.8% |
| EPS (TTM) | ₹25.52 |
Nippon India AMC share price target 2026 to 2030
EPS base ₹25.52 (TTM). Bear: TER cuts plus a flat market — 8% growth, multiple at 28×. Base: folio machine compounds through fee drift — 14% growth at 38×. Bull: SIP culture accelerates, ETF scale pays — 20% growth at 48×.
| Year | Bear (28×, +8%) | Base (38×, +14%) | Bull (48×, +20%) |
|---|---|---|---|
| 2026 | ₹772 | ₹1,105 | ₹1,470 |
| 2027 | ₹833 | ₹1,260 | ₹1,765 |
| 2028 | ₹900 | ₹1,435 | ₹2,115 |
| 2029 | ₹972 | ₹1,640 | ₹2,540 |
| 2030 | ₹1,050 | ₹1,865 | ₹3,050 |
From ₹1,202, the base case is ≈ +55% over four and a half years plus the 1.8% yield; the bear is −13%. AMC downside is fee-and-flow math, not solvency — the range below is where that math starts working hard for you.
Reasons to own Nippon India AMC (at the right price)
- The largest retail folio base — the stickiest money in the industry.
- ETF volume leadership: a free option on India’s passive transition.
- 67% OPM, 44% ROCE, zero debt — toll-booth economics at scale.
- Japanese parent governance rebuilt the franchise after the Reliance era.
- B30-city distribution catches the next hundred million investors first.
The risks: the regulator prices the product, ETF economics are structurally thinner than active, and a prolonged bear market shrinks AUM and multiple together.
Should you buy at the current price?
The live buy range below is for members — the toll booth at a toll-payer’s price.
FAQ
What is the Nippon India AMC share price target for 2030? Base case ≈ ₹1,865 (38× on 14% compounded growth), bear ≈ ₹1,050, bull ≈ ₹3,050. Arithmetic above.
How does NAM-India differ from HDFC AMC? More retail folios and ETF leadership versus HDFC’s equity-AUM share and bank distribution. Nippon grows folios faster; HDFC monetises AUM richer. Owning either is owning the SIP habit.
Does the passive/ETF shift hurt or help? Both: ETFs earn thinner fees (hurts yields) but Nippon’s ETF scale means the passive wave lands disproportionately in its funds (helps AUM). Net effect depends on the pace of the shift.
When are Nippon India AMC’s next results? Track the exact date on our results calendar.
This article is research and education, not personalised investment advice. We are not SEBI-registered advisers. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.